The global Loss of Libido Treatment Market is projected to grow from USD 3.44 billion in 2025 to USD 5.07 billion by 2035 at a CAGR of 4.01% — a market whose growth reflects both growing clinical recognition of hypoactive sexual desire disorder (HSDD) as a legitimate medical condition and increasing patient willingness to seek treatment as social stigma around sexual health...